Brian Cahill
2021
In 2021, Brian Cahill earned a total compensation of $1.9M as Chief Financial Officer at Eagle Pharmaceuticals, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $373,920 |
|---|---|
| Salary | $380,000 |
| Stock Awards | $1,071,649 |
| Other | $30,042 |
| Total | $1,855,611 |
Cahill received $1.1M in stock awards, accounting for 58% of the total pay in 2021.
Cahill also received $373.9K in non-equity incentive plan, $380K in salary and $30K in other compensation.
Rankings
In 2021, Brian Cahill's compensation ranked 6,340th out of 12,415 executives tracked by ExecPay. In other words, Cahill earned more than 48.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,340 out of 12,415 | 49th |
Division Manufacturing | 2,698 out of 5,501 | 51st |
Major group Chemicals And Allied Products | 1,185 out of 2,371 | 50th |
Industry group Drugs | 1,055 out of 2,092 | 50th |
Industry Pharmaceutical Preparations | 764 out of 1,542 | 51st |
Pay ratio
| Brian Cahill's Pay | $1,855,611 |
|---|---|
| Median Employee's Pay | $246,233 |
| Pay Ratio | 8to 1 |
In 2021, the annual total compensation of Brian Cahill was $1,855,611.
The annual total compensation of the median employee at Eagle Pharmaceuticals was $246,233.
The ratio of Brian Cahill's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on June 15, 2022.
Cahill's colleagues
We found four more compensation records of executives who worked with Brian Cahill at Eagle Pharmaceuticals in 2021.